Yeast Genetics and Molecular Biology 2000
University of Washington
Seattle, Washington USA
July 2000


Name: Lew, Daniel J.
Mailing Address: Pharmacology & Cancer Biology, Duke University Medical Center, Research Drive, Durham, NC 27710, USA
Email Address: daniel.lew@duke.edu
Phone & FAX numbers: (919) 613-8627 & (919) 681-1005

#002

A role for the Pkc1p/Mpk1p pathway in the morphogenesis checkpoint.
Jacob C. Harrison, Elaine S.G. Bardes, Daniel J. Lew
Pharmacology & Cancer Biology, Duke University Medical Center, Research Drive, Durham, NC 27710, USA

Environmental perturbations often provoke a transient depolarization of the actin cytoskeleton, during which bud construction is delayed while cells adapt to the insult. In these cells, the morphogenesis checkpoint stabilizes the Swe1p kinase, which accumulates and inhibits Cdc28p, halting the cell cycle in G2 until the actin can repolarize and complete bud construction. Many signaling pathways involve kinase cascades culminating in activation of MAPKs (of which there are 5 in yeast). The Pkc1p/Mpk1p MAPK pathway was specifically required to generate an effective morphogenesis checkpoint response, and actin depolymerization caused a dramatic induction of Mpk1p phosphorylation. Thus, Mpk1p is activated upon actin perturbation and is essential for an effective checkpoint response to such perturbation. The Mpk1p pathway is thought to respond to cell wall/plasma membrane defects through putative plasma membrane sensors (Wsc1p, Mid2p), which activate exchange factors (Rom2p, Rom2p), promoting GTP-loading of Rho1p, which is an activator of Pkc1p. Surprisingly, these pathways were not required for checkpoint function. Stabilization of Swe1p did not compensate for the loss of Mpk1p. However, elimination of Mih1p (the phosphatase that counteracts Swe1p action) suppressed the checkpoint defect of cells lacking Mpk1p. This suggests that the Pkc1p-Mpk1p cascade promotes Mih1p inhibition during a checkpoint response.


Return to YGM 2000 Abstract Index